Atypical Antipsychotic Augmentation for Treatment-Resistant Depression: A Systematic Review and Network Meta-Analysis.
about
Genetics of Common Antipsychotic-Induced Adverse EffectsSecond Generation Antipsychotics in the Treatment of Major Depressive Disorder: An UpdateSafety, tolerability, and risks associated with first- and second-generation antipsychotics: a state-of-the-art clinical review.Comparative efficacy and tolerability of pharmacological and somatic interventions in adult patients with treatment-resistant depression: a systematic review and network meta-analysis.A retrospective study of predictive factors for effective aripiprazole augmentation of antidepressant therapy in treatment-resistant depression.Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological TreatmentsAtypical antipsychotics as add-on treatment in late-life depressionAn Open Label Pilot Study of Adjunctive Asenapine for the Treatment of Posttraumatic Stress Disorder.Treating to target in major depressive disorder: response to remission to functional recovery.Evidence-based pharmacotherapy of treatment-resistant unipolar depression.Clinical response in a risperidone-medicated naturalistic sample: patients' characteristics and dose-dependent pharmacokinetic patterns.Acute and chronic treatment with quetiapine induces antidepressant-like behavior and exerts antioxidant effects in the rat brain.Pharmacological treatment of unipolar depressive disorders: summary of WFSBP guidelines.Korean Medication Algorithm for Depressive Disorders 2017: Third Revision.Efficacy, acceptability, and safety of adjunctive aripiprazole in treatment-resistant depression: a meta-analysis of randomized controlled trials.The Influence of Metabolic Syndrome and Sex on the DNA Methylome in Schizophrenia.Factors associated with first- versus second-generation long-acting antipsychotics prescribed under ordinary clinical practice in Italy
P2860
Q28072893-D398CB9C-A7AE-4FBA-982E-0F39A8442DABQ28076712-B3F1259F-0E87-4A6E-BB69-BA4183BBED5AQ33878816-CB95A5EB-BE12-4F5F-AB69-688A70CD4045Q36236193-0317F6DB-5EC6-49AC-8D45-5B2D8E8A8D1CQ36908442-1EF56C2C-CDDC-41F9-8479-287866415181Q37197216-BDCB30BA-FD94-4FD9-84AF-3B2073C42AFEQ37259428-742601C6-5BF7-4357-8FD9-07B297ACD053Q37299870-01FC2860-18B1-4D16-A3DD-E0F448B17910Q38673546-C223383C-73BC-4C9B-8A3F-D49F993D749BQ39009865-C1B1432D-0CDC-4716-B4A7-C1BBE34981D0Q39329159-C82AC824-95DA-4B03-BDEA-B188E0953EB4Q46370895-B710EE33-7BF0-4CA4-81A7-DBAAE608C5DAQ47927842-722984F8-10B0-4D84-9667-46015A327EB0Q48514039-22D32F11-6E33-412D-AE9B-5D6AFF1D9341Q50075257-9A08EC44-9A26-4D63-A3F2-E634DD292B21Q54959460-AA46C8DC-7315-4260-8C2A-4861372F59EAQ58803803-66D89E99-879C-40A9-821D-00D127659ACC
P2860
Atypical Antipsychotic Augmentation for Treatment-Resistant Depression: A Systematic Review and Network Meta-Analysis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Atypical Antipsychotic Augment ...... iew and Network Meta-Analysis.
@ast
Atypical Antipsychotic Augment ...... iew and Network Meta-Analysis.
@en
type
label
Atypical Antipsychotic Augment ...... iew and Network Meta-Analysis.
@ast
Atypical Antipsychotic Augment ...... iew and Network Meta-Analysis.
@en
prefLabel
Atypical Antipsychotic Augment ...... iew and Network Meta-Analysis.
@ast
Atypical Antipsychotic Augment ...... iew and Network Meta-Analysis.
@en
P2093
P2860
P31
P356
P1476
Atypical Antipsychotic Augment ...... iew and Network Meta-Analysis.
@en
P2093
Arun V Ravindran
Gabor I Keitner
Jingping Zhao
Michael Bauer
Xinyu Zhou
Yuqing Zhang
P2860
P304
P356
10.1093/IJNP/PYV060
P577
2015-05-25T00:00:00Z